Brachytherapy in localized prostatic cancer: 100 Years of radium

Current Opinion in Urology

Volumn 8, Issue 5, 1998, Pages 387-392

  Loch, Tillmann ^a   Kovács, György ^a   Stöckle, Michael ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD 198; IODINE 125; IRIDIUM 192; PALLADIUM; PROSTATE SPECIFIC ANTIGEN; RADIUM;

BRACHYTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; REVIEW; SURVIVAL RATE; TECHNIQUE; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT PLANNING;

EID: 0031757113     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199809000-00005     Document Type: Review

References (15)

1. Prestidge BR, Prete JJ, Buchholz TA, Friedland JL, Stock RG, Grimm DO, Bice WS. A survey of current clinical practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys 1998; 40:461-465. Interesting demographic information.
2. Zelefsky MJ, Whitmore WF. Long-term results of retropubic permanent 125-iodine implantation of the prostate for clinically localized prostatic cancer. J Urol 1997; 158:23-30. Concludes old open brachytherapy era.
3. Holm HH. The history of interstitial brachytherapy of prostatic cancer. Semin Surg Oncol 1997; 13:431-437. Technical development of the new era (founder).
4. Ragde H, Blasko JC, Grimm DO, Kenny GM, Sylvester JE, Hoak DC, Landin K, Cavanagh W. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer 1997; 80:442-453. Initial new-era brachytherapy results.
5. Grove A, McLean B. Taking on prostate cancer. Fortune Magazine 1996; May 13. Reason for publicity of new-era brachytherapy.
6. Wirth B, Kovacs G, Galalae R, Loch T, Bertermann H, Wand H, Kimmig B. Die Strahlentherapie des lokal begrenzten Prostatakarzinoms in Form einer kombinierten HDR-Brachy-und Teletherapie-Erfahrungen bei 158 Patienten. Akt Urol 1996; 27:193-199.
7. Nori D, Moni J. Current issues in techniques of prostate brachytherapy [Review]. Semin Surg Oncol 1997; 13:444-453. Overview of current issues in brachytherapy.
8. Vicini FA, Horwitz EM, Gonzalez J, Martinez AA. Treatment options for localized prostate cancer based on pretreatment serum prostate specific antigen levels [Review]. J Urol 1997; 158:319-325.
9. Powell CR, Huisman TK, Riffenburgh RH, Saunders EL, Bethel KJ, Johnstone PAS. Outcome for surgically staged localized prostate cancer treated with external beam radiation therapy. J Urol 1997; 157:1754-1759.
10. Critz FA, Tarlton RS, Holladay DA. Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. Cancer 1995; 75:2383-2391.
11. Ragde H, Blasko JC, Grimm PD, Kenny GM, Sylvester J, Hoak DC, Cavanagh W, Landin K. Brachytherapy for clinically localized prostate cancer: results at 7-and 8-year follow-up. Semin Surg Oncol 1997; 13:438-443.
12. Ash DV. Management of localized carcinoma of the prostate: brachytherapy revisited [Review]. Clin Oncol (R Coll Radiol) 1997; 9:219-221.
13. Butler EB, Scardino PT, Teh BS, Uhl BM, Guerriero WG, Carlton CE, et al. The Baylor College of Medicine experience with gold seed implantation. Semin Surg Oncol 1997; 13:406-418. Description of the brachytherapy evolution.
14. Loening SA. Gold seed implantation in prostate brachytherapy. Semin Surg Oncol 1997; 13:419-424.
15. Loch T, Wirth B, Kovács G, Bertermann H, Stöckle M. Transrectal ultrasound (TRUS) guided combined high dose rate (HDR) brachytherapy of localised prostate cancer: 10 years of experience with a minimum follow up of 5 years. Eur Urol 1998; 33 (Suppl. 1):54.